{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:31:14Z","timestamp":1792481474692,"version":"4.5.0"},"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T00:00:00Z","timestamp":1459296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1005520","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T22:03:30Z","timestamp":1459375410000},"page":"e1005520","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":197,"title":["Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection"],"prefix":"10.1371","volume":"12","author":[{"given":"Kshitij","family":"Wagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmoy","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Bayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jetta","family":"Garrity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Rademeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Lapedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark K.","family":"Louder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim Abdool","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel C.","family":"Nussenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette","family":"Korber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-030409-101256","article-title":"The role of antibodies in HIV vaccines","volume":"28","author":"JR Mascola","year":"2010","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.immuni.2012.08.012","article-title":"Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies","volume":"37","author":"PD Kwong","year":"2012","journal-title":"Immunity"},{"issue":"6151","key":"ref3","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1241144","article-title":"Antibodies in HIV-1 vaccine development and therapy","volume":"341","author":"F Klein","year":"2013","journal-title":"Science"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nri3516","article-title":"Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning","volume":"13","author":"PD Kwong","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"e8805","DOI":"10.1371\/journal.pone.0008805","article-title":"Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals","volume":"5","author":"D Corti","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1084\/jem.20120423","article-title":"Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein","volume":"209","author":"F Klein","year":"2012","journal-title":"J Exp Med"},{"issue":"7238","key":"ref7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature07930","article-title":"Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals","volume":"458","author":"JF Scheid","year":"2009","journal-title":"Nature"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jim.2008.11.012","article-title":"A method for identification of HIV gp140 binding memory B cells in human blood","volume":"343","author":"JF Scheid","year":"2009","journal-title":"J Immunol Methods"},{"issue":"7365","key":"ref9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"LM Walker","year":"2011","journal-title":"Nature"},{"issue":"5950","key":"ref10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"LM Walker","year":"2009","journal-title":"Science"},{"issue":"5993","key":"ref11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"X Wu","year":"2010","journal-title":"Science"},{"issue":"7498","key":"ref12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature13036","article-title":"Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies","volume":"509","author":"NA Doria-Rose","year":"2014","journal-title":"Nature"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"E Falkowska","year":"2014","journal-title":"Immunity"},{"issue":"7525","key":"ref14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature13601","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface","volume":"515","author":"J Huang","year":"2014","journal-title":"Nature"},{"issue":"7424","key":"ref15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"J Huang","year":"2012","journal-title":"Nature"},{"issue":"7446","key":"ref16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"HX Liao","year":"2013","journal-title":"Nature"},{"issue":"47","key":"ref17","doi-asserted-by":"crossref","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"H Mouquet","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.celrep.2014.04.001","article-title":"Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike","volume":"7","author":"L Scharf","year":"2014","journal-title":"Cell Rep"},{"issue":"6049","key":"ref19","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"JF Scheid","year":"2011","journal-title":"Science"},{"issue":"49","key":"ref20","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1073\/pnas.1415789111","article-title":"Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex","volume":"111","author":"D Sok","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2014.01.052","article-title":"Structural insights on the role of antibodies in HIV-1 vaccine and therapy","volume":"156","author":"AP West Jr.","year":"2014","journal-title":"Cell"},{"issue":"5187","key":"ref22","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody","volume":"266","author":"DR Burton","year":"1994","journal-title":"Science"},{"issue":"21","key":"ref23","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1128\/JVI.02213-14","article-title":"Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo","volume":"88","author":"RS Rudicell","year":"2014","journal-title":"J Virol"},{"issue":"6049","key":"ref24","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"X Wu","year":"2011","journal-title":"Science"},{"issue":"5993","key":"ref25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"T Zhou","year":"2010","journal-title":"Science"},{"issue":"7129","key":"ref26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature05580","article-title":"Structural definition of a conserved neutralization epitope on HIV-1 gp120","volume":"445","author":"T Zhou","year":"2007","journal-title":"Nature"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","article-title":"Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies","volume":"39","author":"T Zhou","year":"2013","journal-title":"Immunity"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"e1003342","DOI":"10.1371\/journal.ppat.1003342","article-title":"Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans","volume":"9","author":"JP Julien","year":"2013","journal-title":"PLoS Pathog"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nsmb.2594","article-title":"Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120","volume":"20","author":"L Kong","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"6059","key":"ref30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1213256","article-title":"A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield","volume":"334","author":"R Pejchal","year":"2011","journal-title":"Science"},{"issue":"236","key":"ref31","doi-asserted-by":"crossref","first-page":"236ra63","DOI":"10.1126\/scitranslmed.3008104","article-title":"Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV","volume":"6","author":"D Sok","year":"2014","journal-title":"Sci Transl Med"},{"key":"ref32","article-title":"A new member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency","author":"NA Doria-Rose","year":"2015","journal-title":"J Virol"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1073\/pnas.1217537110","article-title":"Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9","volume":"110","author":"JP Julien","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7377","key":"ref34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature10696","article-title":"Structure of HIV-1 gp120 V1\/V2 domain with broadly neutralizing antibody PG9","volume":"480","author":"JS McLellan","year":"2011","journal-title":"Nature"},{"issue":"16","key":"ref35","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1128\/JVI.00966-10","article-title":"Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1","volume":"84","author":"M Pancera","year":"2010","journal-title":"J Virol"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nsmb.2600","article-title":"Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16","volume":"20","author":"M Pancera","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"25","key":"ref37","doi-asserted-by":"crossref","first-page":"11483","DOI":"10.1073\/pnas.1004600107","article-title":"Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1","volume":"107","author":"R Pejchal","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.immuni.2004.12.011","article-title":"Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41","volume":"22","author":"RM Cardoso","year":"2005","journal-title":"Immunity"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1128\/JVI.67.11.6642-6647.1993","article-title":"A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1","volume":"67","author":"T Muster","year":"1993","journal-title":"J Virol"},{"issue":"19","key":"ref40","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1128\/JVI.78.19.10724-10737.2004","article-title":"Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope","volume":"78","author":"G Ofek","year":"2004","journal-title":"J Virol"},{"issue":"22","key":"ref41","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41","volume":"75","author":"MB Zwick","year":"2001","journal-title":"J Virol"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2014.04.008","article-title":"Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers","volume":"40","author":"C Blattner","year":"2014","journal-title":"Immunity"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.chom.2012.09.008","article-title":"A Blueprint for HIV Vaccine Discovery","volume":"12","author":"DR Burton","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coviro.2015.04.002","article-title":"Strategies to guide the antibody affinity maturation process","volume":"11","author":"NA Doria-Rose","year":"2015","journal-title":"Curr Opin Virol"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nbt.2197","article-title":"B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study","volume":"30","author":"BF Haynes","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/imr.12075","article-title":"HIV-1 neutralizing antibodies: understanding nature&apos;s pathways","volume":"254","author":"JR Mascola","year":"2013","journal-title":"Immunol Rev"},{"issue":"8","key":"ref47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nm.1974","article-title":"Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques","volume":"15","author":"AJ Hessell","year":"2009","journal-title":"Nat Med"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/72318","article-title":"Protection of macaques against vaginal transmission of a pathogenic HIV-1\/SIV chimeric virus by passive infusion of neutralizing antibodies","volume":"6","author":"JR Mascola","year":"2000","journal-title":"Nat Med"},{"issue":"46","key":"ref49","doi-asserted-by":"crossref","first-page":"18921","DOI":"10.1073\/pnas.1214785109","article-title":"Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo","volume":"109","author":"B Moldt","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"ref50","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1128\/JVI.75.17.8340-8347.2001","article-title":"Antibody protects macaques against vaginal challenge with a pathogenic R5 simian\/human immunodeficiency virus at serum levels giving complete neutralization in vitro","volume":"75","author":"PW Parren","year":"2001","journal-title":"J Virol"},{"issue":"243","key":"ref51","doi-asserted-by":"crossref","first-page":"243ra88","DOI":"10.1126\/scitranslmed.3008992","article-title":"Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor","volume":"6","author":"A Pegu","year":"2014","journal-title":"Sci Transl Med"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1128\/JVI.00210-15","article-title":"Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian\/Human Immunodeficiency Virus Infection","volume":"89","author":"KO Saunders","year":"2015","journal-title":"J Virol"},{"issue":"7475","key":"ref53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12746","article-title":"Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia","volume":"503","author":"M Shingai","year":"2013","journal-title":"Nature"},{"issue":"7475","key":"ref54","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature12744","article-title":"Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys","volume":"503","author":"DH Barouch","year":"2013","journal-title":"Nature"},{"issue":"7427","key":"ref55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"F Klein","year":"2012","journal-title":"Nature"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1084\/jem.20141050","article-title":"Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants","volume":"211","author":"F Klein","year":"2014","journal-title":"J Exp Med"},{"issue":"7557","key":"ref57","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"M Caskey","year":"2015","journal-title":"Nature"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1128\/JVI.06745-11","article-title":"HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes","volume":"86","author":"NA Doria-Rose","year":"2012","journal-title":"J Virol"},{"issue":"19","key":"ref59","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1128\/JVI.01414-12","article-title":"A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection","volume":"86","author":"L Goo","year":"2012","journal-title":"J Virol"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/JVI.03136-14","article-title":"Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes","volume":"89","author":"R Kong","year":"2015","journal-title":"J Virol"},{"issue":"6193","key":"ref61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1255512","article-title":"Immunologic strategies for HIV-1 remission and eradication","volume":"345","author":"DH Barouch","year":"2014","journal-title":"Science"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.cell.2014.07.043","article-title":"Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice","volume":"158","author":"A Halper-Stromberg","year":"2014","journal-title":"Cell"},{"issue":"41","key":"ref63","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1073\/pnas.1315295110","article-title":"HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice","volume":"110","author":"JA Horwitz","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref64","doi-asserted-by":"crossref","first-page":"e1004271","DOI":"10.1371\/journal.ppat.1004271","article-title":"Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization","volume":"10","author":"AS Kim","year":"2014","journal-title":"PLoS Pathog"},{"issue":"8","key":"ref65","doi-asserted-by":"crossref","first-page":"e1005110","DOI":"10.1371\/journal.ppat.1005110","article-title":"Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies","volume":"11","author":"LE McCoy","year":"2015","journal-title":"PLoS Pathog"},{"issue":"8","key":"ref66","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1073\/pnas.1314718111","article-title":"Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity","volume":"111","author":"R Cimbro","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"ref67","doi-asserted-by":"crossref","first-page":"10510","DOI":"10.1128\/JVI.00552-10","article-title":"Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16","volume":"84","author":"KJ Doores","year":"2010","journal-title":"J Virol"},{"issue":"13","key":"ref68","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1128\/JVI.00230-15","article-title":"Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance","volume":"89","author":"LK Pritchard","year":"2015","journal-title":"J Virol"},{"issue":"3","key":"ref69","first-page":"470","article-title":"Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1","volume":"161","author":"X Wu","year":"2015","journal-title":"Infection. Cell"},{"issue":"6","key":"ref70","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","article-title":"Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors","volume":"161","author":"T Zhou","year":"2015","journal-title":"Cell"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1038\/ncomms9443","article-title":"Dose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies","volume":"6","author":"NE Webb","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virol.2011.09.019","article-title":"Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors","volume":"422","author":"TJ Ketas","year":"2012","journal-title":"Virology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The Toxicity of Poisons Applied Jointly","volume":"26","author":"CI Bliss","year":"1939","journal-title":"Annals of Applied Biology"},{"key":"ref74","article-title":"Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults","author":"JE Ledgerwood","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"ref75","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.2649","article-title":"A quantitative basis for antiretroviral therapy for HIV-1 infection","volume":"18","author":"BL Jilek","year":"2012","journal-title":"Nat Med"},{"issue":"7","key":"ref76","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm1777","article-title":"Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs","volume":"14","author":"L Shen","year":"2008","journal-title":"Nat Med"},{"issue":"6","key":"ref77","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2014.08.023","article-title":"Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity","volume":"158","author":"S Bournazos","year":"2014","journal-title":"Cell"},{"issue":"7158","key":"ref78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"AJ Hessell","year":"2007","journal-title":"Nature"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-59745-170-3_26","article-title":"Measuring HIV neutralization in a luciferase reporter gene assay","volume":"485","author":"DC Montefiori","year":"2009","journal-title":"Methods Mol Biol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","article-title":"Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1","volume":"409","author":"M Sarzotti-Kelsoe","year":"2014","journal-title":"J Immunol Methods"},{"issue":"3","key":"ref81","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JVI.02108-09","article-title":"Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies","volume":"84","author":"MS Seaman","year":"2010","journal-title":"J Virol"},{"issue":"16","key":"ref82","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"M Li","year":"2005","journal-title":"J Virol"},{"issue":"7524","key":"ref83","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nature13612","article-title":"Enhanced neonatal Fc receptor function improves protection against primate SHIV infection","volume":"514","author":"SY Ko","year":"2014","journal-title":"Nature"},{"key":"ref84","volume":"xii","author":"RP Brent","year":"1972"},{"key":"ref85","volume":"xxvi","author":"WH Press","year":"1992"},{"key":"ref86","unstructured":"Jones E, Oliphant, T., Peterson, P. SciPy: Open source scientific tools for Python 2001- <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.scipy.org2015\" xlink:type=\"simple\">http:\/\/www.scipy.org2015<\/ext-link>."},{"issue":"16","key":"ref87","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"JD Storey","year":"2003","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1005520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T23:49:02Z","timestamp":1600386542000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1005520"}},"subtitle":[],"editor":[{"given":"Ronald C.","family":"Desrosiers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":87,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1005520","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,30]]}}}